Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02JYA
|
|||
| Former ID |
DNAP001277
|
|||
| Drug Name |
Raxibacumab
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | Anthrax [ICD-11: 1B97; ICD-9: 22] | Approved | [1] | |
| Company |
GlaxoSmithKline
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Bacterial Protective antigen (Bact pagA) | Target Info | Modulator | [1] |
| Pathway Interaction Database | Cellular roles of Anthrax toxin | |||
| Reactome | Uptake and function of anthrax toxins | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550). J Immunol. 2011 Apr 1;186(7):4234-43. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.